agilon health, inc. (AGL)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 4.34B |
| Enterprise value | 3.83B |
| Trailing P/E | N/A |
| Forward P/E | 59.52 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.05 |
| Price/book (mrq) | 4.98 |
| Enterprise value/revenue | 0.91 |
| Enterprise value/EBITDA | -61.41 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.95 |
| 52-week change 3 | -37.26% |
| S&P500 52-week change 3 | 11.63% |
| 52-week high 3 | 29.44 |
| 52-week low 3 | 10.67 |
| 50-day moving average 3 | 16.23 |
| 200-day moving average 3 | 20.04 |
Share statistics
| Avg vol (3-month) 3 | 2.79M |
| Avg vol (10-day) 3 | 3.07M |
| Shares outstanding 5 | 406.04M |
| Implied shares outstanding 6 | 406.04M |
| Float 8 | 301.59M |
| % held by insiders 1 | 1.10% |
| % held by institutions 1 | 108.48% |
| Shares short (14 Nov 2023) 4 | 49.33M |
| Short ratio (14 Nov 2023) 4 | 13.71 |
| Short % of float (14 Nov 2023) 4 | 42.92% |
| Short % of shares outstanding (14 Nov 2023) 4 | 12.15% |
| Shares short (prior month 12 Oct 2023) 4 | 44.59M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2022 |
| Most-recent quarter (mrq) | 29 Sept 2023 |
Profitability
| Profit margin | -2.12% |
| Operating margin (ttm) | -4.03% |
Management effectiveness
| Return on assets (ttm) | -4.28% |
| Return on equity (ttm) | -9.08% |
Income statement
| Revenue (ttm) | 4.19B |
| Revenue per share (ttm) | 10.17 |
| Quarterly revenue growth (yoy) | 75.00% |
| Gross profit (ttm) | 112.29M |
| EBITDA | -123.01M |
| Net income avi to common (ttm) | -88.59M |
| Diluted EPS (ttm) | -0.22 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 564.22M |
| Total cash per share (mrq) | 1.39 |
| Total debt (mrq) | 51.76M |
| Total debt/equity (mrq) | 5.94% |
| Current ratio (mrq) | 1.50 |
| Book value per share (mrq) | 2.15 |
Cash flow statement
| Operating cash flow (ttm) | -144.99M |
| Levered free cash flow (ttm) | -107.99M |
© 2023 Yahoo. All rights reserved.